Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Proof of Principle Program - Phase II

McGill University

$73,500.00

Generation of a gene expression-based breast cancer prognostic device

FY 2009-10

Summary
The tissue surrounding a tumor can have a profound impact on cancer progression and outcome. Dr. Park's laboratory has developed a list of genes from a study of the supporting tissue surrounding breast tumors. The pattern of expression of these genes predicts disease recurrence and outcome. In the study proposed here, we, together with Xceed Molecular, will investigate whether this gene list can be used on an automated gene expression analysis system which can be deployed in hospital laboratories(Xceed's Ziplex Workstation). Our goal is to develop a system to generate rapid and reliable predictions of breast cancer outcome, allowing clinicians to identify patients needing additional therapy.
Program
Proof of Principle Program - Phase II
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
184840
Name
Park Morag
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Xceed Molecular (Toronto, ON); Xceed Molecular (Toronto, ON)
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Proof of Principle
Projecttitle
Generation of a gene expression-based breast cancer prognostic device
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$73,500
Cihrequipment2
$0
Programname2
Proof of Principle Program - Phase II
Keyworddelim
Breast Cancer; Gene Expression; Gene Signatures; Microarray; Microenvironment; Prognostic Predictors
Abstract
The tissue surrounding a tumor can have a profound impact on cancer progression and outcome. Dr. Park's laboratory has developed a list of genes from a study of the supporting tissue surrounding breast tumors. The pattern of expression of these genes predicts disease recurrence and outcome. In the study proposed here, we, together with Xceed Molecular, will investigate whether this gene list can be used on an automated gene expression analysis system which can be deployed in hospital laboratories(Xceed's Ziplex Workstation). Our goal is to develop a system to generate rapid and reliable predictions of breast cancer outcome, allowing clinicians to identify patients needing additional therapy.
Competitiondate
200904
Approvedterm2
1 yr 0 mth
Pinamesdelim
Park, Morag
Approvedterm
1 an 0 mois
Cihrcontribution2
Knowledge Translation Branch~ $73,500~ $0~